✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
The clinical and hematological data of the index case, his father and mother showed that homozygous or heterozygous Hb Q-Iran has no clinical importance.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The first observation of homozygote Hb Q-Iran (α1 75(EF4) Asp-His) is presented in this report.
📊
Key Findings & Data:The first observation of homozygote Hb Q-Iran (α1 75(EF4) Asp-His) is presented in this report.
💡
Conclusion & Impact:The clinical and hematological data of the index case, his father and mother showed that homozygous or heterozygous Hb Q-Iran has no clinical importance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Homozigot · Çocuk · okul öncesi
Abstract
The first observation of homozygote Hb Q-Iran (α1 75(EF4) Asp-His) is presented in this report. The clinical and hematological data of the index case, his father and mother showed that homozygous or heterozygous Hb Q-Iran has no clinical importance.
Özet
Sivas kökenli anormal hemoglobini olan bir çocuğa moleküler analizle Homozigot Hb Q-Iran (α1 75(EF4)Asp-His tanısı konulmuştur.
Keywords
🔖
Cite This Article
ÖZDAĞ, H., YILDIZ, İ., AKAR, N. (2008). Homozigot Hb Q İran'ın (alpha 75 (EF4) ASP-HIS) ilk kez belirlenmesi. Turkish Journal of Hematology, Cilt: 25 - Sayı: 1, 48–50. https://ajindex.com/articles/413188